Neovalen (Benzylpenicillin)

Benzylpenicillin is used to treat infections caused by susceptible bacteria, primarily targeting the Gram‑positive and some Gram‑negative organisms.

• Streptococcal infections: eradicates Streptococcus species causing pharyngitis, scarlet fever, and cellulitis.
• Penicillin‑sensitive staphylococcal infections: treats skin and soft‑tissue infections caused by susceptible Staphylococcus aureus.
• Pneumococcal infections: effective against Streptococcus pneumoniae in pneumonia and meningitis.
• Early syphilis: eliminates Treponema pallidum in primary and secondary stages.
• Meningococcal infections: used for Neisseria meningitidis meningitis.

• Benzylpenicillin inhibits bacterial cell wall synthesis by binding irreversibly to penicillin‑binding proteins (PBPs) that catalyze the final cross‑linking steps of peptidoglycan formation. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis, particularly in actively dividing, susceptible organisms.

Adverse reactions to benzylpenicillin can vary from mild to severe and should be monitored during therapy.

Common Side Effects

• Injection site pain: local discomfort or erythema at the site of administration.
• Diarrhea: mild gastrointestinal upset occurring during treatment.
• Nausea: transient feeling of queasiness.
• Rash: non‑specific skin eruption.
• Fever: low‑grade temperature rise.
• Headache: mild to moderate head discomfort.

Serious or Rare Side Effects

• Anaphylaxis: rapid, life‑threatening allergic reaction requiring immediate medical attention.
• Severe allergic reactions: including angioedema and bronchospasm.
• Clostridioides difficile‑associated diarrhea: colitis caused by disruption of normal gut flora.
• Serum sickness‑like reaction: fever, arthralgia, and rash occurring days after exposure.
• Hemolytic anemia: immune‑mediated destruction of red blood cells.
• Nephritis: inflammation of the kidneys presenting with hematuria or proteinuria.

Before initiating benzylpenicillin therapy, clinicians should consider several safety measures.

• Allergy assessment: avoid in patients with known penicillin hypersensitivity.
• Renal function: adjust dosage in severe renal impairment to prevent accumulation.
• Pregnancy: use only if clearly needed after risk‑benefit assessment.
• Concomitant antibiotics: avoid simultaneous use with bacteriostatic agents that may antagonize its effect.
• Monitoring: observe for signs of hypersensitivity during the first administration.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Benzylpenicillin may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Methotrexate: increased toxicity and bone‑marrow suppression.
• Oral contraceptives: reduced hormonal efficacy, risk of unintended pregnancy.
• Probenecid: decreases renal excretion, raising penicillin levels.
• Bacteriostatic antibiotics (e.g., tetracyclines, chloramphenicol): antagonistic effect on bacterial killing.

Moderate Interactions (Monitor Closely)

• Aminoglycosides: monitor renal function due to additive nephrotoxicity.
• Warfarin: may enhance anticoagulant effect; check INR regularly.